Prashant Chawla, MD
Neuroradiology · Chicago, ILNPI 1457349979
Payments from drug & device makers
What this record shows
37 manufacturers reported payments, led by Telix Pharmaceuticals at 46.6% of the total. 2025 is the largest year on record at $2,881, 5.5 times the $528 reported in 2019.
Across 93 payments — averaging $51.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Telix Pharmaceuticals$2K
- United Imaging Healthcare North America, Inc.$279
- Ipsen Biopharmaceuticals, Inc$229
- GE HealthCare$168
- Progenics Pharmaceuticals, Inc.$153
- Blue Earth Diagnostics$145
- plus $2K from 31 others
What the payments were for
- Consulting fees$2,20046%
- Food & beverage$2,61754%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Telix Pharmaceuticals | 6 | $2,247 |
| United Imaging Healthcare North America, Inc. | 1 | $279 |
| Ipsen Biopharmaceuticals, Inc | 8 | $229 |
| GE HealthCare | 2 | $168 |
| Progenics Pharmaceuticals, Inc. | 2 | $153 |
| Blue Earth Diagnostics | 2 | $145 |
| Incyte Corporation | 6 | $143 |
| Amgen | 5 | $130 |
| Puma Biotechnology, Inc. | 6 | $126 |
| Karyopharm Therapeutics Inc. | 5 | $126 |
| Siemens Medical Solutions USA, Inc. | 6 | $125 |
| Bayer | 5 | $89 |
| Leica Microsystems Inc. | 2 | $68 |
| Tesaro, Inc. | 3 | $64 |
| Johnson & Johnson | 2 | $63 |
| Exelixis Inc. | 3 | $57 |
| Kyowa Kirin, Inc. | 3 | $56 |
| Acell, Inc. | 2 | $52 |
| GSK | 2 | $50 |
| Seagen Inc. | 3 | $45 |
| Boehringer Ingelheim | 2 | $39 |
| Stemline Therapeutics Inc. | 1 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $34 |
| AstraZeneca | 2 | $32 |
| Genmab U.S., Inc. | 1 | $30 |
| Lilly USA, LLC | 1 | $27 |
| Sanofi | 1 | $24 |
| Curium US LLC | 1 | $23 |
| Immunogen, Inc. | 1 | $23 |
| Agios Pharmaceuticals, Inc. | 1 | $20 |
| Sobi, Inc | 1 | $19 |
| Hologic Inc | 1 | $18 |
| Tolmar Pharmaceuticals, Inc. | 1 | $18 |
| EMD Serono, Inc. | 1 | $17 |
| Eisai Inc. | 1 | $16 |
| Novartis | 1 | $13 |
| Novocure Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,817 in reported general payments places this provider in the 80th percentile of 36 neuroradiology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neuroradiology in Chicago
- Benjamin LiuChicago$23K
- Ramez AbdallaChicago$10K
- Donald CantrellChicago$8K
- Okan InceChicago$3K
- Mehmet KocakChicago$3K
- Tarek HijazChicago$2K
- Mohamed EldeenChicago$1K
- Alexander ZartaiskyChicago$1K
- Sharon ByrdChicago$629
- Miral JhaveriChicago$520
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.